Savant Capital’s Pediatrix Medical MD Stock Holding History

Savant Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,879	Closed	-$195K	–	1288
2024 Q4	$195K	Buy	14,879 +83	+0.6%	+$1.15K	﹤0.01%	1326
2024 Q3	$171K	Sell	14,796 -16,107	-52%	-$152K	﹤0.01%	1298
2024 Q2	$233K	Buy	30,903 +18,289	+145%	+$151K	﹤0.01%	1078
2024 Q1	$127K	Buy	+12,614	New	+$117K	﹤0.01%	1063

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Savant Capital's MD Position: Q1 2025 in Review

Savant Capital sold out of Pediatrix Medical (MD) in Q1 2025, closing a stake of 14,879 shares — an estimated $195K sold.

Savant Capital first reported a position in MD in Q1 2024 and held it in 4 quarters. The position peaked at $233K in Q2 2024. 241 funds tracked by Wall St. Rank hold MD as of Q1 2025.

Savant Capital reported no remaining Pediatrix Medical position as of Q1 2025 after selling out during the quarter.
Savant Capital sold 14,879 Pediatrix Medical shares in Q1 2025, an estimated $195K.
Savant Capital first reported a position in Pediatrix Medical in Q1 2024 and held it in 4 quarters.
Savant Capital's Pediatrix Medical position peaked at $233K in Q2 2024.
241 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2025.

Based on Savant Capital's 13F filing for Q1 2025, filed 8 May 2025.